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A B S T R A C T   
Cystic fibrosis (CF) is a disease characterized by bacterial chronic infection of the respiratory tract and 
inflammation, which leads to a progressive decrease in lung function. Pseudomonas aeruginosa is commonly 
isolated from the sputum of patients and their presence is associated with a predominant airway inflammation 
with neutrophils, causing chronic colonization and higher mortality rates. Neutrophil extracellular traps (NETs) 
have been observed in response against Pseudomonas, however, these cannot eliminate the pathogen from the 
respiratory tract, so one possibility is that the bacteria could promote their production to use them as a scaffold to 
colonize the lungs and as a nutrient source, however, their overproduction could also lead to increased damage to 
the lungs. In this work, we evaluated NETs formation by Pseudomonas clinical isolates obtained from CF patients 
and found that these induced NETs formation with globular or spread morphologies, of note, we found that there 
is a trend by which the spread forms were induced mainly by isolates obtained from patients with severe disease, 
whereas, the globular morphologies were observed for isolates obtained from patients with mild/moderate 
disease. Finally, we screened for bacterial molecules implicated in NETs formation and found that Exotoxin S, 
pyocin S2 and pyoverdine could participate in the process.   
1. Introduction 
Cystic fibrosis (CF) is a genetic disease caused by mutations of the 
cystic fibrosis transmembrane regulator (CFTR) gene, located on chro-
mosome 7. This gene encodes a protein member of the ATP-binding 
cassette (ABC) transporter superfamily, which functions as a chloride 
channel that controls the transport of ions and water across epithelial 
tissues. The clinical manifestations of the CF are dominated by respi-
ratory and gastrointestinal symptoms, such as chronic airway infection 
and inflammation, which lead to a progressive decrement in lung 
function, pancreatic insufficiency, malnutrition, and hepatobiliary 
symptoms, among others (Knowles and Durie, 2002). Lung disease is 
characterized by chronic bacterial infections, in which Pseudomonas 
aeruginosa is the major pathogen involved, overproducing thick mucus 
and neutrophil-predominant airway inflammation (Regamey et al., 
2012). 
Despite the neutrophilic infiltrate, neutrophils are not able to elim-
inate bacteria from the airway, but contribute to lung damage (Kelly 
et al., 2008). In response to infection, neutrophils migrate to the site of 
inflammation and, once activated, perform different functions, 
including phagocytosis and secretion of proteins and enzymes by 
degranulation (Cortjens et al., 2016). In addition, neutrophils have the 
ability to kill pathogens by releasing neutrophil extracellular traps 
(NETs) (Brinkmann et al., 2004; Brinkmann and Zychlinsky, 2012). To 
release NETs, neutrophils undergo morphological changes leading to the 
extrusion of the nuclear content creating fiber-like structures, composed 
of DNA mixed with granular and nuclear proteins (Cortjens et al., 2017). 
Although it has been proposed that the formation of NETs has 
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antimicrobial activity in CF, evidence suggests that they contribute to 
lung inflammation and tissue damage (Lynch and Bruce, 2013). In CF 
patients, NETs are present in the sputum and their abundance contrib-
utes to mucus viscosity, due to a particularly high DNA content (Man-
zenreiter et al., 2012; Martinez-Aleman et al., 2017). Pseudomonas 
aeruginosa has been recognized as one of the most prominent pathogens 
in CF patients, causing chronic colonization and higher rates of 
morbidity and mortality. Additionally, it has been previously reported 
that these bacteria are also one of the main inducers of NETs release in 
CF, which could be correlated with increased damage to the lungs 
leading to decreased pulmonary function (Yoo et al., 2014). Information 
about the molecules of this pathogen related to NETs induction is scanty; 
however, this pathogen encodes several virulence factors that could be 
implicated in this process. 
P. aeruginosa produces virulence factors that can be actively secreted 
into the extracellular medium, or that can be injected directly into the 
cells through type III secretion systems (TTSS) to promote bacterial 
establishment and proliferation by inhibiting the host immune response 
(Garai et al., 2019; Kuchma et al., 2005). It is well characterized that 
these bacteria produce diffusible pigments such as pyocyanin and pyo-
verdine, thus avoiding elimination by the immune system through their 
free radical scavenging activity in immune cells (Morel et al., 1992; 
Vinckx et al., 2010). Exoenzymes secreted by TTSS allow the bacteria to 
modify the host cells and prevent the immune response. In this regard, 
Exoenzyme S (ExoS) enhances the persistence and spread of Pseudo-
monas in the lungs of patients by inhibiting phagocytosis and bacterial 
destruction within the phagocytic cells, which has important effects in 
acute pneumonia (Rangel et al., 2015). The implication of these proteins 
in NETs formation can be proposed, since it is known that free radical 
formation and phagocytosis are essential steps in the formation of some 
types of NETs (Johnson et al., 2017; Van Avondt and Hartl, 2018). 
CF patients are commonly coinfected with different bacterial species, 
and this may be correlated with their disease status due to increased 
tissue damage caused by the immune response or by bacterial toxic 
factors (Bhagirath et al., 2016). Additionally, an aspect that could also 
contribute to damage is intra- and interspecific bacterial competition in 
patient’s lungs. Pyocins S1 and S2 are bacteriocins whose activity has 
been observed in Pseudomonas isolates from CF patients. It has been 
described that these proteins can promote cell death of other bacteria 
through their DNase activity and lipid modification (Ling et al., 2010; 
Sano et al., 1993). Likewise, it has also been shown that they are able to 
induce the cell death of mammalian cells (Abdi-Ali et al., 2004; Wata-
nabe and Saito, 1980); therefore, the activity of these proteins could also 
contribute to increase the severity of the disease in patients. On the other 
hand, since the modification of chromatin is important for NETs for-
mation, it is tempting to analyze the possible role of these proteins in the 
process. 
In the present work, we evaluated the NETs formation induced by 
Pseudomonas aeruginosa strains isolated from CF patients and observed 
whether a correlation could be established between NETs formation and 
the clinical status of the patients. Furthermore, we identified some 
bacterial molecules that could participate in the process. 
2. Methods 
2.1. Patients 
We sampled strains of Pseudomonas aeruginosa from sputum cultures 
and/or throat swab from 14 patients with CF, which were recruited at 
the University Hospital and the School of Medicine of the Autonomous 
University of Nuevo Leon in Monterrey, Mexico. Our study protocol was 
approved by the Ethics and Research Committees of the University 
Hospital (Registration no. NM11015 and MB16− 00002). We obtained 
an appropriate written informed consent from the patients, or their 
caregivers. High-resolution chest computed tomography (HRCT) was 
performed and evaluated using the Bhalla score (Bhalla et al., 1991). 
Pulmonary function tests were performed by spirometry following the 
guidelines of the American Thoracic Society (Miller et al., 2005) Tests 
were conducted using the Platinum EliteSeries™, BreezeSuite™ version 
7.2 SP3 plethysmograph (MGC Diagnostics, St. Paul, MN, USA). Results 
are expressed as the percentage of the predicted values for FEV1by sex, 
age and height. To stablish chronic colonization by Pseudomonas aeru-
ginosa, the criteria established by Lee and cols. previously was followed 
(Lee et al., 2003), for this, a total of 6 bacterial cultures from sputum 
were carried out for each patient in one year and in for those cases in 
which Pseudomonas aeruginosa was isolated in at least 4 occasions the 
patient was classified as chronic. Pancreatic insufficiency/sufficiency 
was determined by Computed tomography (CT) scanning. 
2.2. P. aeruginosa strains 
To carry out this study, we used 14 clinical isolates from patients 
with CF isolated in the bacteriology laboratory located in the regional 
center for the control of infectious diseases of the Faculty of Medicine of 
the Autonomous University of Nuevo Leon, and 5 mutant strains by 
transposon insertion of P. aeruginosa PW1059 (PAORF PA0044; exoT), 
PW4736 (PAORF PA2191; exoY), PW7478 (PAORF PA3841; exoS), 
PW3083 (PAORF PA1150; pys2), PW5032 (PAORF PA2396; pvdF) and 
their parental strain PAO1 were obtained from the University of 
Washington, USA Pseudomonas aeruginosa mutant strain collection (Ja-
cobs et al., 2003). All strains were reactivated in tubes with Luria Bertani 
liquid medium (LB) and incubated at 37 ◦C with gentle shaking at 
200 rpm for 24 h (Labnet International, Inc. Model 222 DS Edison, NJ). 
We recorded tubes with presence or absence of pigment in the LB me-
dium, since a green coloration suggestive of pyoverdine was primarily 
observed in most of the tubes, pigment production was monitored at 
400 nm with a Multiskan Sky Microplate Spectrophotometer (Thermo 
scientific). Subsequently, each strain of P. aeruginosa was seeded in Petri 
dishes with Cetrimide Agar (BD Bioxon), incubated at 42 ◦C for 24 h 
(Thermo Fisher Scientific, Inc. Model 815, Waltham, MA), and stored at 
4 ◦C until later use. To identify Pseudomonas aeruginosa, bacteria inoc-
ulum of each isolate was identified by using API 20NE (bioMérieux; 
France). 
2.3. P. aeruginosa inoculum preparation 
Culture tubes with P. aeruginosa bacterial growth were centrifuged at 
1500 g for 15 min, the bacterial pellet was resuspended in 1 mL of RPMI 
medium (Life Technologies, Mainway Drive Burlington, ONT), 
measured in the microplate reader (Bio-Rad, Hercules, CA) at λ600 nm, 
and adjusted to 1 OD (optical density) (equivalent to 1 × 107 bacteria/ 
mL) in the microplate reader (Bio-Rad. Hercules, CA). From this bacte-
rial concentration, we prepared multiplicities of infection for each 
experiment by serial dilutions. 
2.4. Determination of the biofilm formation index (BFI) 
For this we followed a previous stablished protocol (Delissalde and 
Amabile-Cuevas, 2004) with few modifications. Briefly, clinical isolates 
of Pseudomonas aeruginosa were incubated in a BHI broth at 37 ◦C with 
shaking for 24 h. After this, they were adjusted to 1OD at 600 nm, then 
100 μL of the culture was transferred to a 96 wells microplate and 
incubated at 37 ◦C for 24 h. After this, absorbance at 630 nm was 
determined with a Multiskan Sky microplate reader (Thermo), super-
natant was removed and each well was washed with 200 μL of sterile 
distilled water, biofilm adhered to the surface was stained for 15 min 
with 200 μL crystal violet (0.1 % w / v), three more washes were per-
formed and biofilm was solubilized with 200 μL of 95 % ethanol for 
5 min at room temperature and absorbance was determined at 570 nm 
on the microplate reader. The Biofilm Formation Index (BFI) was 
determined with the formula: BFI = (AB– CW) / G, where AB is the 
optical density at 570 nm of the stained bacteria, CW is the optical 
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density at 570 nm of the medium culture (free of microorganisms) 
stained and G corresponds to the optical density at 630 nm of cell 
growth in unstained suspended culture. According to the IFB value, the 
biofilm is considered: strong if IFB is ≥1.10, moderate if it is between 
0.70–1.09, weak between 0.35− 0.69 and no biofilm if the BFI is ≤0.35. 
2.5. Neutrophil isolation 
Peripheral blood from healthy individuals was collected in tubes 
with EDTA (BD, Franklin Lakes, NJ). 7 mL of whole blood were laid on 
top of the equivalent amount of Histopaque 119 (Sigma-Aldrich, St. 
Louis, MO) in two conical 15 mL tubes. The tubes were centrifuged at 
800 g for 20 min, with no brake. The layer containing the PMNs was 
collected using a Pasteur pipette, washed with 10 mL of PBS 1x, and 
centrifugated at 300 g for 10 min. The pellet from each tube was sus-
pended in 2 mL of PBS 1 × . The neutrophils were further purified by a 
Percoll (Sigma-Aldrich, St. Louis, MO) gradient. In brief, five Percoll 
dilutions at 85, 80, 75, 70, and 65 % were prepared with PBS 1x from a 
100 % stock solution (9 parts Percoll plus 1-part PBS 10x). Next, in 
15 mL tubes, 2 mL of each dilution was consecutively placed from high 
to low concentration, and at the end, the PMNs were laid over the gra-
dients. The gradients were centrifuged for 20 min at 800 g (no brake), 
and then, the interphase between the 70 % and 75 % dilutions was 
collected and washed with PBS 1x by centrifugation at 300 g for 10 min. 
Finally, the neutrophils were resuspended in 2 mL of RPMI medium, 
quantified in a Neubauer chamber, and their viability was determined 
by trypan blue exclusion. 
2.6. NETs Induction and quantification by nuclear expansion 
1 × 105 neutrophils (≥ 95 % viability) were seeded in 24-well plates 
in RPMI medium and allowed to adhere for 20 min at room temperature. 
Subsequently, 50 μL of P. aeruginosa (MOI 1:100, 1:10, 1:1 and 1:0.1), or 
supernatant obtained by filtration through 0.22 μM membranes at 3% or 
30 % (final concentration in the well) for isolate 131752 and 30 % for all 
other isolates were added. As controls, non-stimulated neutrophils, 
neutrophils incubated with non-pathogenic Escherichia coli (MOI 1:10), 
and neutrophils stimulated with 40 nM of PMA (Sigma, Saint Louis, MO) 
were used. The cells were incubated at 37 ◦C for 3 h, and then 10 μL of 
the Sytox® Green dye 0.5 mM (Molecular probes, Life Techonologies, 
Eugene, OR) was added to each well and incubated at room temperature 
in darkness for 15 min. After, NETs were quantified by fluorescence 
intensity in a fluorometer (Thermo Scientific, Inc., Model 5210450. 
Waltham, MA), and by nuclear expansion as reported previously 
(Papayannopoulos et al., 2010). In brief, phase contrast and fluores-
cence images were acquired with a fluorescence microscope using the 
FITC filter (Ex = 480 and Em = 535) with 20x objective lenses (Zeiss 
Axioplan, West Germany). On these, a total of 600 cells per treatment 
were analyzed using ImageJ software, and the distribution of the num-
ber of cells across the range of nuclear area was obtained using the 
frequency function of Microsoft Excel. The Sytox-positive counts were 
divided by the total number of cells, determined from corresponding 
phase contrast images (Sytox/Total cells), and plotted as the percentage 
of Sytox-positive cells within each area range. By using this method, a 
cell ongoing NETs formation has decondensed nucleus exceeding the 
normal average area of the nucleus of an unstimulated neutrophil, which 
is ±80 μm2, assuming a circular shape, and using the formula π x r2. 
2.7. NETs categorization 
To distinguish the different nuclear morphologies, we based our 
analysis on the nuclear changes that occurs during NETs formation as 
described by Hakkim et. al. (Hakkim et al., 2011), coupled with nuclear 
area quantification described previously (Gonzalez et al., 2014; 
Papayannopoulos et al., 2010). Briefly, we classify nuclear morphology 
by arbitrarily subdividing the NETs extension as “diffused” for those 
cells in which the nuclear area expanded above 80 μm2 (normal size of 
neutrophil nucleus) but below 160 μm2, and “spread” for the cells in 
which the nuclear expansion was greater than 160 μm2. For the stacked 
analysis the nuclear expansion data showed in Figs. 1D and Fig. 2E were 
joined to group the clinical isolates of P. aeruginosa according to the type 
of NETs induced by both, the bacteria and their secreted products. 
2.8. Fluorescence quantification 
To quantitate the NETs induced after incubation of neutrophils with 
the Pseudomonas aeruginosa mutant strains, we took images with the 40x 
objective for each condition of at least 10 different fields (randomly 
selected) and calculated the Corrected Total Field fluorescence (CTFF) 
for each treatment using the ImageJ software (protocol established by 
the QBI Advanced Microscopy Facility, The University of Queensland, 
Australia with some modifications). To do this, first a rectangular ROI 
(region of interest) of 200 × 200 (Width x Height) was established and 
the parameters analyzed were the area size, the mean fluorescence and 
the integrated density (which represents the total amount of fluores-
cence in the box) for each treatment. The background was established by 
measuring an area without fluorescence. The results obtained were 
pasted into a Excel spreadsheet and the CTFF was calculated with the 
formula: CTFF = Integrated Density – (Area of selected cell X Mean 
fluorescence of background readings). Finally, the CTFF of each treat-
ment was graphed using GraphPad Prism 8 software. 
2.9. Statistical analysis 
Analysis of variance (ANOVA) was carried out to determine the 
significant differences in the induction of the NETs by P. aeruginosa 
when using the fluorometry technique. When fluorescence intensity was 
carried out, one-way ANOVA with multiple comparisons was performed 
for each molecule analyzed. To determine the statistical significance 
among the different NETs morphologies (globular and spread) non- 
parametric Wilcoxon signed-rank test were carried out. Analyses were 
performed in GraphPad Prism 8 software. 
3. Results 
3.1. Characteristics of the CF patient cohort 
The clinical data of the patients and detailed information on the 
status of their disease are shown in Table 1. Clinical analysis showed that 
some of the patients had respiratory problems and chest X-rays corre-
sponding to an advanced disease. It should be noted that the age of the 
patient could be a determining factor in our cohort, since almost all 
patients aging 12 years and older had a moderate to severe status ac-
cording to their Bhalla score (a score that considerate multiple factors in 
the patient disease status like the severity and extend of bronchiectasis, 
peribronchial thickening, mucous plugs and presence of abscesses or 
sacculations, extent of emphysema, number of bullae, collapse or 
consolidation in the lungs). Chronic colonization with P. aeruginosa was 
stablished for each patient isolate following Lee‘s criteria, and found 
that half of our isolates corresponded to chronic colonization, of note, 
we found that mucous or rough morphologies not correlated with 
chronic colonization since almost all our isolated presented mucous 
phenotypes except but one. 
Additionally, analysis of pancreatic insufficiency demonstrated that 
in our cohort not all of the patients presented pancreatic problem 
independently of its age or the mutation it carries. 
3.2. Pseudomonas aeruginosa isolates from CF patients possess high 
capacity to induce NETs 
We sought to analyze the capacity to induce NETs of P. aeruginosa 
clinical isolates of CF patients. We next assayed if these bacteria 
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presented increased capacity to induce formation of extracellular traps 
from NETs. In order to do this, we tested the multiplicity of infection 
(MOI) necessary to induce NETs of an isolate coming from a patient 
suffering of a chronic infection; we found that this strain possess high 
capacity to induce NETs, a capacity not displayed by and intestinal 
isolate of Escherichia coli. Importantly, we observed that Pseudomonas 
isolates possess a very high capacity to promote NETs formation (MOI 
1:0.1; neutrophil: bacteria ratio), which is comparable to that induced 
with the positive PMA control (Fig. 1A). For this, we used the 0.1 MOI in 
the following experiments. 
As demonstrated by fluorescence microscopy, this bacterium has a 
varied capacity to induce NETs, since some isolates showed high 
inducing capacity, while others proved to be poor inducers (Fig. 1B). 
Quantification of the extruded DNA by fluorometry corroborated our 
previous result, as most of our isolates promoted increased DNA extru-
sion when compared to PMA (Fig. 1C). Microscopy images showed 
different NETs morphology for many isolates, with some of the strains 
promoting DNA extrusion with a spread morphology (isolate 131716), 
while others induced a more globular morphology (isolates 140859, 
140559, 131723, 140164, 132166) (Fig. 1B). To quantify the different 
morphologies, we analyzed the NETs by measuring the nuclear expan-
sion. We observed that some of them promoted expansion of the nucleus 
in a spread form similar to that observed after treatment with PMA, 
while other isolates induced a more compact form (Fig. 1D). Taken 
together, we found that P. aeruginosa possess a strong capacity to induce 
NETs with a varied nuclear morphology. 
3.3. Secreted factors of P. aeruginosa clinical isolates participate in NETs 
formation 
We first isolated and characterized the bacterial phenotype; for this 
we separated our clinical isolates by analyzing if they were able to 
Fig. 1. Pseudomonas aeruginosa isolates induces extensive NETs. A) Fluorescence microscopy images of non-treated neutrophils (Naive) or treated with bacteria at 
different multiplicities of infection (MOI) and stained with Sytox to detect extracellular DNA after 3 h of treatment are shown. The treatments were: PMA (40 nM), 
non-pathogenic Escherichia coli (EC), and Pseudomonas clinical isolate (131716). B) Neutrophils were incubated with different Pseudomonas isolates at a MOI of 0.1 for 
3 h and NETs morphology was detected by Sytox staining. C) NETs induced by each of the 14 CF isolates (MOI 1:0.1), PMA, E. coli or left untreated were quantified 
by fluorometry. The mean and the standard deviation are shown, the results are representative of three independent experiments and each condition was tested in 
triplicate. **** p ≤ 0.0001. D) Nuclear area quantification of non-treated (Naive) neutrophils, PMA- treated or incubated with Pseudomonas aeruginosa isolates (MOI 
1:0.1) is shown. The nuclear area of neutrophils after stimulation was calculated as indicated in the Materials and Methods section, and the value corresponding to a 
given nuclear area range was plotted against the percentage of Sytox positive cells. Results are representative of three independent experiments and each condition 
was tested in triplicate. 
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change the color of their growth medium, since this a simple way to 
know which isolates were able to secrete metabolites (i.e. pyocyanin or 
pyoverdine, among others). We found great variability among our 
strains, as some showed high and fast secretion, whereas others showed 
poor or even null pigment production (Fig. 2A). In an attempt to analyze 
if pigment production was related to the chronicity of the infection, we 
analyzed the bacterial phenotype in culture and found that the majority 
of our isolates presented a mucous colonial phenotype however, not all 
of them were obtained from patients with chronic infection (Table 1). 
After, to analyze if the mucous phenotype could be correlated with 
exopolysaccharide production to form biofilms we assayed the capacity 
of some isolates to form biofilms in vitro and found that all the isolates 
were strong biofilm inducers although in different levels (Fig. 2B), 
however, biofilm formation was independent of their capacity to pro-
duce diffusible pigments. 
Next, we incubated neutrophils with two concentrations (3% and 30 
Fig. 2. Biofilm formation by Pseudomonas aeruginosa isolates and NET induction by its secreted factors. A) Pseudomonas CF isolates demonstrated variable pigment 
production when cultured in liquid medium, all the isolates were categorized according to their pigment production as shown in table. B) Biofilm formation of 
representative Pseudomonas aeruginosa isolates was determined and expressed as Biofilm Formation Index (BFI). BFI is strong if ≥1.10, moderate if 0.70-1.09, weak if 
0.35-0.69 or negative if ≤0.35 (as indicated in materials and methods) C) Neutrophils were incubated with filtered supernatant of Pseudomonas isolates at different 
concentrations (30 % final concentration in the well unless indicated differently), after 3 h extracellular DNA was stained with Sytox and visualized by fluorescence 
microscopy. D) NETs induced by supernatant of each isolate, PMA, supernatant of E. coli (EC) or left untreated were quantified by fluorometry. The mean and the 
standard deviation are shown, the results are representative of three independent experiments and each condition was tested in triplicate. **** p ≤ 0.0001. E) 
Nuclear area quantification was determined as described before and plotted against the percentage of Sytox positive cells. Results are representative of three in-
dependent experiments and each condition was tested in triplicate. 
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%) of bacterial supernatant from a pigment producer isolate (131752). 
We found that both tested concentrations induced NETs, we observed 
that the highest concentration induced more robustly, for this reason we 
selected the 30 % concentration for the next experiments (Fig. 2C). To 
analyze if this was a conserved trait among the pigment-producers 
strains we extended the analysis to include additional strains (140859, 
131723) and found that the NETs morphologies is not dependent on 
pigment production as a mixture of globular and extended morphologies 
were observed. When supernatant of some poor or not-pigment pro-
ducer isolates (132166,140164 and 132150) were incubated with neu-
trophils, they could also induce robust NETs formation with mixed 
morphologies (Fig. 2C). Moreover, when extruded DNA was quantified 
by fluorometry, most of the strains were characterized as strong NETs 
inducers, as these produced more NETs than PMA (Fig. 2D) and these 
results were confirmed by nuclear expansion quantification (Fig. 2E). 
3.4. P. aeruginosa clinical isolates and their secreted products induce 
NETs with varied morphology 
Analyses of nuclear expansion quantification demonstrated that our 
isolates or their supernatant possess different capacity to induce NETs 
with a heterogeneous morphology (Fig. 1D and 2E). The analysis 
revealed that all the isolates were able to induce globular NETs although 
in different extent, however, their capacities to induce spread NETs was 
more variable. In an attempt to observe if the NETs morphology could be 
correlated with the disease status of the patient, we grouped the isolates 
according to their capacity to induce NETs measured by nuclear 
expansion (Fig. 1D and 2E) and the Bhalla score of the patient from 
which they were obtained (Fig. 3). By doing this we corroborated that 
both the bacteria and their secreted factors induced NETs, however, we 
observed that when NETs were induced with bacteria there is a trend in 
which the higher the Bhalla score increases the amount of expanded 
NETs and, conversely, the lower the score the more globular NETs are 
induced (Fig. 3, top panel). On the other hand, when the ability of 
bacterial supernatants to induce NETs with varied morphologies was 
analyzed, no identifiable trend was found (Fig. 3, bottom panel). How-
ever, in this case the percentage of total NETs induced did demonstrate a 
trend to increase according to the severity of the disease. 
3.5. Pyoverdine, leucine aminopeptidase (ExoS), and pyocin S2 from 
Pseudomonas participate in NETs formation 
Since we found that secreted factors could contribute to NETs 
induction in our strains and according to literature we decided to 
analyze if virulence factors pyoverdine and pyocin S2 or exotoxins ExoS, 
ExoT and ExoY of Pseudomonas could be participating in NETs induction. 
In order to analyze whether these proteins were implicated in NETs 
formation, we performed an experiment using mutant bacteria to each of 
these factors (Fig. 4A). We found that incubation of neutrophils with 
defective strains for pyoverdine, pyocin S2 or ExoS showed a decreased 
NETs formation when compared to that observed for the parental strain 
PAO1 or PMA, as was determined by fluorescence microscopy (Fig. 4B), 
and fluorescence quantification (Fig. 4C). Finally, we also tested mutant 
bacteria for ExoT and ExoY but no NETs reduction was observed (Fig. 4B 
and C). 
4. Discussion 
Decreased respiratory capacity due increased mucus production in 
lungs of CF patients has been recognized as one of the main problems 
associated with mutation in the CFTR channel. However, recent research 
described that high amounts of extracellular DNA also have an impor-
tant role in worsening patients’ health (Marcos et al., 2015; Rada, 
2017b). Neutrophils are the main cells recruited to patients’ airways, 
however, they are incapable to eliminate bacteria and, instead, through 
NETs formation, their granular components are released leading to 
increased tissue damage, perhaps functioning as scaffold for the estab-
lishment of polymicrobial infections (Rahman and Gadjeva, 2014). In 
this regard, one important aspect to be considered is NETs morphology, 
which is still poorly understood, but which may be highly relevant, as 
the extent of tissue damage is possibly dependent on this feature. The 
observation of extended DNA fibers decorated with lytic granules has 
been commonly referred to as NETs, however, there are reports in which 
it is possible to observe “globular” or “extended” NETs morphologies 
that seem to be related to the stimulus used (Campos-Garcia et al., 2019; 
Kenny et al., 2017). In the present article, we observed that P. aeruginosa 
isolates or their secreted factors induce NET with globular or expanded 
morphologies. Likewise, the proportion of each of these morphologies 
seems to have a trend that could be correlated with the disease state of 
the patient. Therefore, we think that the characterization of the capacity 
of bacterial isolates to induce NETs and their different morphologies 
may be a useful tool to determine the disease status of patients, as it has 
been described that in response to infection, the neutrophil infiltration 
occurs before the onset of symptoms (Yonker et al., 2015). However, if 
these morphologies can be presented individually or if the globular 
forms precede the extended forms and these are subsequently extended 
Table 1 
Patient clinical data.  
Registry 
No. 














140859 F508del/F508del Men 11 yes no 7 104 yes yes 
140559 F508del/x Women 5 no no 6 84 yes yes 
132019 F508del / G542X Men 1 yes no 2 ND yes no 
131608 G542x/x Women 15 yes yes 11 87 no yes 
131723 ND Women 1 yes no 1 ND yes yes 
131752 F508del/R334 Men 1 yes no 1 ND yes yes 
131785 F508del /F508del Women 13 yes yes 8 66 yes yes 
131754 2789 + 5G > A/ 
2789 + 5G > A 
Women 20 yes yes 14 25 no yes 
140084 F508del /X Women 2 yes no 1 ND yes yes 
140164 F508del /3849 + 10 K Women 13 yes yes 8 78 no no 
131716 F508del/F508del Men 12 yes yes 14 28 yes yes 
132166 F508del /G85E Men 5 yes yes 2 95 yes no 
132176 1148 T/X Men 12 yes no 7 80 yes yes 
131640 S549 N/S549N Men 20 yes yes 14 33 yes no 
Pa mucoid: Mucoid Pseudomonas aeruginosa. 
Pa Chronic: Chronic Pseudomonas aeruginosa using Lee’s Criteria (Lee et al., 2003). 
Bhalla score: 1–5 Medium, 6–9 Moderate, >9 Severe (Bhalla et al., 1991). 
FEV1 %: Percentage of predicted Forced expiratory volume in 1 s. 
ND: No Data. 
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by the effect of flow, has yet to be studied. 
P. aeruginosa can actively colonize patient’s lungs and establish 
chronic infections (Bhagirath et al., 2016; Murray et al., 2007; Rada, 
2017a); it has been demonstrated however that neutrophils from pa-
tients are able to recognize the bacteria and extrude NETs, although 
some clinical isolates are able to acquire resistance to NETs mediated 
killing (Young et al., 2011). Resistance mechanisms have not been fully 
elucidated; however, it has been proposed that nuclease secretion or the 
acquisition of mucoid phenotypes can help individually or synergisti-
cally for this purpose (Wilton et al., 2018; Young et al., 2011). Therefore, 
it could be possible for clinical isolates to promote the formation of NETs 
to be used as scaffolding to establish infection in the lungs, while pre-
venting their antimicrobial function. In our work, most isolates pre-
sented a mucous phenotype, and all were able to induce NETs formation; 
however, the amount and morphologies of the induced NETs were 
different. We think that the reason behind this could reside in the 
virulence factors expressed in our clinical isolates. 
Growth in liquid media showed that some isolates produced pig-
ments while others did not, among the pigments that have been deter-
mined to be secreted into the environment by this bacterium are 
pyocyanin and pyoverdine. It was previously shown that mutant bac-
teria for pyocyanin mildly decreased NET formation (Rada et al., 2013), 
but so far, pyoverdine had not been related to NETs. Here we showed a 
decreased NETs induction after incubation of neutrophils with mutant 
bacteria for pyoverdine. We think that the possible role of these mole-
cules in NETs induction reside in their capacity to regulate free radical 
production in neutrophils, as it has been shown that pyocyanin can in-
crease ROS production through NADPH oxidase activation and pyo-
verdine levels are increased as a response in oxidative stress conditions 
(Rada et al., 2013; Vinckx et al., 2008). On the other hand, pyoverdine 
Fig. 3. Nuclear expansion morphologies induced by Pseudo-
monas aeruginosa isolates or their secreted factors. a) Nuclear 
area expansion of neutrophils treated with bacteria or their 
secretion products was quantified. For this, when the neutro-
phil nuclei possessed areas higher than 80 μm2 (average size of 
normal nucleus in neutrophils) but smaller than 160 μm2 were 
classified as globular nucleus and plotted against the percent-
age of Sytox positive cells b) Spread NETs were designated for 
those cases in which bacteria or its supernatants induced nu-
clear expansion with areas higher than 160 μm2 but smaller 
than 320 μm2, the results were plotted against the percentage 
of Sytox positive cells. In both graphs the isolates where clas-
sified according to the Bhalla score of the patients and stacked 
analyses shown the amount of spread NETs induced by the 
bacteria or their supernatant. Non-parametric Wilcoxon ana-
lyses were performed to determine the significance among the 
different morphologies for the isolates. The results are repre-
sentative of three independent experiments for each condition.   
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may help the bacteria to resist its elimination by the immune response, 
as it possesses a free radical scavenging ability (Morel et al., 1992). 
Nevertheless, other not-producing pigment isolates were also able to 
induce robust NETs formation, indicating that these bacterial pigments 
are not the only molecules involved in this process. 
ExoS is an exoenzyme secreted by the type III secretion system that 
inhibits phagocytosis when interacts with phagocytic cells (Garai et al., 
2019; Rocha et al., 2003). It has been reported that phagocytosis defects 
or when this cannot be carried out then NETs can be formed (Branzk 
et al., 2014; Manfredi et al., 2018). In our work, this was supported by 
the use of an ExoS mutant, as we observed that, when neutrophils were 
incubated with this strain, NETs induction decreased perhaps as a 
possible effect of increased bacterial phagocytosis and elimination. On 
the other hand, It has also been described that Pseudomonas biofilm 
formation 
promotes ExoS deregulation (Hogardt et al., 2004), since all of our 
isolates were able to form biofilms this could be inconsistent with our 
results. A possible explanation for this difference is that in the 
mentioned work they used the Pseudomonas strain PAO1, and we used 
clinical strains where it is known that these strains can possess hyper-
mutable phenotypes that allow their maintenance and establishment in 
the patient’s lungs (Hogardt and Heesemann, 2013). Furthermore, we 
did not analyze the phenotype of our isolates, but it could be possible 
that some may possess an ExoS / ExoU phenotype whose presence has 
been linked as high-risk clones among clinical strains (Horna et al., 
2019). In addition, another possibility is that biofilm formation could 
promote ExoS dysregulation, but would promote increased production 
of pyoverdine (Kang and Kirienko, 2017; Kang et al., 2017; Visaggio 
Fig. 4. ExoS, Pyocin S2 and pyoverdine of Pseudomonas aeruginosa participate in NETs formation. A) Transposon insertion mutant bacteria and their predicted 
inhibited function used in this study B) Fluorescence microscopy images of non-treated neutrophils (Naive), PMA-treated, parental Pseudomonas strain PAO1 or 
mutant bacteria treated (MOI 1:10) were stained with Sytox to detect extracellular DNA after 3 h of treatment. C) NETs induced were quantified by fluorescence 
intensity. The corrected total field fluorescence (CFFT) for each treatment was quantified as described in materials and methods. The mean and the standard de-
viation of at least 10 different fields for each treatment are shown. ** p ≤ 0.009, **** p ≤ 0.0001. 
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et al., 2015) and pyocins (Oluyombo et al., 2019; Smith et al., 2012) in 
Pseudomonas isolates that we found to also participate in NET formation. 
An observation attracting our attention was the diminished NETs 
formation induced by pyocin S2 mutant strains. Pyocin S2 has been 
characterized as a bacteriocin; however, during infection, it has been 
shown that this molecule may enter mammalian cells after being 
recognized by transferrin receptors in the membrane and then, through 
a hormone-like mechanism, it reaches the nucleus where it exerts its 
cytotoxic effect (Abdi-Ali et al., 2004; Farkas-Himsley and Musclow, 
1986). During NETs formation, DNA decondensation by neutrophil’s 
elastase activity and in some cases, through PAD4 activity is a primor-
dial step (Papayannopoulos et al., 2010; Saha et al., 2019). We think that 
Pseudomonas isolates may contribute to this step through pyocin S2 
DNAse activity, which promotes extensive NETs formation in the pa-
tients by increasing the tissue damage, leading to diminished respiratory 
capacity. Although our work suggests the participation of pyoverdine, 
exoS as well as pyocinS2 in the formation of NETs, it is not possible for us 
at this point to correlate the activity of any of these individually with the 
morphology of NETs. We are currently working to investigate if there is 
a synergistical effect between these molecules, or if they have an inde-
pendent effect in order to known if the NETs morphologies correlate 
with their activities. 
An important perspective in our work is to analyze the killing ca-
pacity of the different morphologies of NETs induced by our isolates. We 
think that NETs morphology could play an important role in their killing 
activities, as the expanded phenotypes could be more effective in 
entrapping and preventing the dispersion of bacteria, but they are less 
effective in killing, since the local concentration of antimicrobial mol-
ecules contained in them is more disperse. In contrast, NETs with a small 
expanded nucleus or with globular morphologies may be less effective to 
entrap bacteria but could have an increased killing activity. Another 
possibility is that the expanded NETs phenotype could produce a greater 
area of damage in patients, decreasing their respiratory capacity in 
comparison to that induced by the globular morphologies. 
NETs formation should be a process regulated by the neutrophils, 
although it could be beneficial in the antimicrobial response, it can also 
be detrimental for the organism, due to the large number of harmful 
components released to the extracellular space. The recent description 
of bacterial proteins as potent NETs inducers is interesting, as it offers a 
new insight into the immunopathology caused by these diseases. It is 
noteworthy that, although NETs were described more than a decade ago, 
many aspects still remain to be discovered due to the difficulties asso-
ciated to their study. However, new pathways implied in their formation 
are constantly being discovered, which provide additional insights in the 
process that could lead to the development of new therapeutic measures 
or of new strategies that may allow to know the state of the diseases in 
which these structures have an important role. 
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